Decision making in the management of benign prostatic enlargement and the role of transabdominal ultrasound

To assess the benefit and safety of composite therapy (Tamsulosin and Trospium drugs) in treating benign prostatic enlargement complain, mainly overactive urinary bladder symptoms. OBJECTIVE: The study has been designed to estimate the benefit and safety of Trospium and Tamsulosin in processing of symptoms of excessive bladder and benign prostate hyperplasia (BPH). Patients and Methods: Prospective clinical trial study conducted at Al-Diwaniya teaching hospitals and private clinics from march 2016 to march 2017, to patients BPH and bothersome symptoms. 60 patients were treated with Tamsulocin and 60 patients were treated by Tamsulocin and Trospium. RESULTS: Median scores of IPSS, OABSS, and QOL proved no big difference between two study sets before staring treatment (P = 0.544), (P = 0.287) , (P = 0.668) consecutively. After one month, both treatments led to a big reduction in IPSS, OABSS median score; (P < 0.001), (P < 0.001). Following three months, both treatments resulted in significant reduction in IPSS (P < 0.001), OABSS (P < 0.001), QOL result, (P < 0.001) consecutively. Conclusion: These results suggest which treatment with Trospium and tamsulosin therapy provides benefit for men with natural - Syndrome of the acute urinary tract and benign enlarged prostate.

Download Full-text

Validation of a clinical decision-making Markov model applied to optimization of benign prostatic enlargement treatment

European Urology Supplements ◽

10.1016/s1569-9056(19)31374-0 ◽

2019 ◽

Vol 18 (1) ◽

pp. e1897

Author(s):

R. Ferrari ◽

R. Schiavina ◽

M. Borghesi ◽

L. Bianchi ◽

F. Chessa ◽

...

Keyword(s):

Decision Making ◽

Markov Model ◽

Clinical Decision Making ◽

Clinical Decision ◽

Benign Prostatic Enlargement ◽

Prostatic Enlargement

Download Full-text

Role of UPP in evaluating bladder outlet obstruction due to benign prostatic enlargement

Neurourology and Urodynamics ◽

10.1002/nau.20227 ◽

2007 ◽

Vol 26 (6) ◽

pp. 842-846 ◽

Cited By ~ 7

Author(s):

Qiang Fang ◽

Bo Song ◽

Weibing Li ◽

Gensheng Lu ◽

Xiyu Jin ◽

...

Keyword(s):

Bladder Outlet Obstruction ◽

Outlet Obstruction ◽

Benign Prostatic Enlargement ◽

Prostatic Enlargement

Download Full-text

COMPARISON OF PROSTATE VOLUME MEASURED BY TRANSABDOMINAL ULTRASOUND AND TRANSRECTAL ULTRASOUND IN PATIENT WITH LUTS DUE TO BENIGN PROSTATIC ENLARGEMENT

Journal of Evidence Based Medicine and Healthcare ◽

10.18410/jebmh/2017/546 ◽

2017 ◽

Vol 4 (45) ◽

pp. 2748-2754

Author(s):

Thakappa Narayanrao Gachchi ◽

Ramalingaiah Karadakere Hanumegowda ◽

Jagruthi Sundar ◽

Keshavamurthy Rammaiah ◽

Mahohar Chikkamoga Siddaiah

Keyword(s):

Prostate Volume ◽

Transrectal Ultrasound ◽

Transabdominal Ultrasound ◽

Benign Prostatic Enlargement ◽

Prostatic Enlargement

Download Full-text

A Review of Intravesical Prostatic Protrusion in the Evaluation and Treatment of Benign Prostatic Enlargement

European Journal of Medical and Health Sciences ◽

10.24018/ejmed.2021.3.1.648 ◽

2021 ◽

Vol 3 (1) ◽

pp. 13-17

Author(s):

Balantine U. Eze ◽

Okwudili C. Amu ◽

Jude A. Edeh

Keyword(s):

Treatment Option ◽

Symptom Severity ◽

English Language ◽

Diagnostic Value ◽

Benign Prostatic Obstruction ◽

Benign Prostatic Enlargement ◽

Non Invasive ◽

Prostatic Enlargement ◽

Intravesical Prostatic Protrusion

The evaluation of severity of symptoms, tracking complications, choosing effective and efficient approach to treatment, and prognosis is important in benign prostatic enlargement (BPE) patients. Measurement of intravesical prostatic protrusion (IPP) is an easy, affordable and non-invasive marker for benign prostatic obstruction with a high diagnostic value. This study aims to undertake a descriptive review of current literature for the role of IPP in the evaluation and treatment of patients with BPE. Relevant articles written in English language were retrieved from PubMed and Google Scholar. Keywords used for searching articles included intravesical prostatic Protrusion and Benign Prostatic Enlargement/ hyperplasia/ Obstruction; evaluation; and treatment. Papers published between January 1990 and October 2020 were extracted and evaluated. The analyzed studies showed that IPP can be assessed by various modalities and is important in the evaluation of symptom severity, tracking progression and complications of disease, choosing treatment option and prognostication. It is important that IPP be always assessed at the point of initial evaluation of BPE patients.

Download Full-text

Medical treatment for benign prostatic hyperplasia: Where do we stand?

Urologia Journal ◽

10.1177/0391560319859785 ◽

2019 ◽

Vol 86 (3) ◽

pp. 115-121

Author(s):

Marta Rossanese ◽

Alessandro Crestani ◽

Antonino Inferrera ◽

Gianluca Giannarini ◽

Riccardo Bartoletti ◽

...

Keyword(s):

Decision Making ◽

Urinary Tract ◽

Medical Treatment ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Benign Prostatic Enlargement ◽

Urinary Tract Symptoms ◽

Prostatic Enlargement ◽

Lower Urinary

Male lower urinary tract symptoms are frequently due to benign prostatic enlargement. Medical therapy is strongly recommended in patients with moderate to severe symptoms. Lower urinary tract symptoms may require a different medical approach using drugs with different mechanisms of action. Alpha-1 blockers, muscarinic receptor antagonists and phosphodiesterase type 5 inhibitors are the most frequently used drugs. 5-Alpha reductase inhibitors are commonly prescribed to reduce prostate volume and to prevent benign prostatic hyperplasia progression. Currently, medical treatment of lower urinary tract symptoms suggestive of benign prostatic enlargement can be tailored according to different symptom characteristics and severity, and to different patient comorbidities and preferences. For this reason, the decision-making process should be based on an accurate patient counselling with detailed clarification of potential benefits and, above all, potential side effects of different drugs. This non-systematic review of the literature presents an update of the current options for medical treatment of lower urinary tract symptoms suggestive of benign prostatic enlargement, helping urologists in the decision-making and counselling process.

Download Full-text

A 2014 snapshot audit of the role of urodynamics in the UK for benign prostatic enlargement surgery

Neurourology and Urodynamics ◽

10.1002/nau.22704 ◽

2014 ◽

Vol 35 (2) ◽

pp. 271-272 ◽

Cited By ~ 2

Author(s):

N. Thiruchelvam ◽

M.J. Drake ◽

S. Venn ◽

R. Morley ◽

Keyword(s):

Benign Prostatic Enlargement ◽

Prostatic Enlargement ◽

The Uk

Download Full-text

Elaborating the role of reflection and individual differences in the study of folk-economic beliefs

Behavioral and Brain Sciences ◽

10.1017/s0140525x18000274 ◽

2018 ◽

Vol 41 ◽

Author(s):

Kevin Arceneaux

Keyword(s):

Decision Making ◽

Individual Differences ◽

Cognitive Processes ◽

Evolutionary History ◽

Behavioral Responses ◽

History Of ◽

Economic Beliefs

AbstractIntuitions guide decision-making, and looking to the evolutionary history of humans illuminates why some behavioral responses are more intuitive than others. Yet a place remains for cognitive processes to second-guess intuitive responses – that is, to be reflective – and individual differences abound in automatic, intuitive processing as well.

Download Full-text

The Role of Shared Decision-Making in Audiologic Rehabilitation

Perspectives on Aural Rehabilitation and Its Instrumentation ◽

10.1044/arri21.1.15 ◽

2014 ◽

Vol 21 (1) ◽

pp. 15-23 ◽

Cited By ~ 6

Author(s):

Helen Pryce ◽

Amanda Hall

Keyword(s):

Decision Making ◽

Shared Decision Making ◽

Behavior Changes ◽

Shared Decision ◽

Patient Centered ◽

Treatment Information ◽

Centered Care ◽

Potential Risks ◽

Audiologic Rehabilitation

Shared decision-making (SDM), a component of patient-centered care, is the process in which the clinician and patient both participate in decision-making about treatment; information is shared between the parties and both agree with the decision. Shared decision-making is appropriate for health care conditions in which there is more than one evidence-based treatment or management option that have different benefits and risks. The patient's involvement ensures that the decisions regarding treatment are sensitive to the patient's values and preferences. Audiologic rehabilitation requires substantial behavior changes on the part of patients and includes benefits to their communication as well as compromises and potential risks. This article identifies the importance of shared decision-making in audiologic rehabilitation and the changes required to implement it effectively.

Download Full-text